Sponsored Links

BRIEF-Elan says FY earnings rise to $220 mln

DUBLIN | Wed Feb 6, 2013 2:07am EST

DUBLIN Feb 6 (Reuters) - Elan Corporation PLC : * Announces that it has agreed to restructure the tysabri collaboration with

Biogen Idec Inc * Says posted FY revenues $1.2 billion, adjusted EBITDA increased by over 30

percent to $220 million
Stocks
Markets
Healthcare
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.